330 related articles for article (PubMed ID: 22230779)
21. Biocatalytic ketone reduction--a powerful tool for the production of chiral alcohols-part II: whole-cell reductions.
Goldberg K; Schroer K; Lütz S; Liese A
Appl Microbiol Biotechnol; 2007 Aug; 76(2):249-55. PubMed ID: 17486338
[TBL] [Abstract][Full Text] [Related]
22. Building blocks.
Hilterhaus L; Liese A
Adv Biochem Eng Biotechnol; 2007; 105():133-73. PubMed ID: 17408083
[TBL] [Abstract][Full Text] [Related]
23. Palladium coupling catalysts for pharmaceutical applications.
Doucet H; Hierso JC
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):672-90. PubMed ID: 17987520
[TBL] [Abstract][Full Text] [Related]
24. Sustainable biocatalytic synthesis of L-homophenylalanine as pharmaceutical drug precursor.
Ahmad AL; Oh PC; Abd Shukor SR
Biotechnol Adv; 2009; 27(3):286-96. PubMed ID: 19500550
[TBL] [Abstract][Full Text] [Related]
25. Biocatalysis for the synthesis of pharmaceuticals and pharmaceutical intermediates.
Sun H; Zhang H; Ang EL; Zhao H
Bioorg Med Chem; 2018 Apr; 26(7):1275-1284. PubMed ID: 28709846
[TBL] [Abstract][Full Text] [Related]
26. Biocatalytic synthesis of intermediates for the synthesis of chiral drug substances.
Patel RN
Curr Opin Biotechnol; 2001 Dec; 12(6):587-604. PubMed ID: 11849941
[TBL] [Abstract][Full Text] [Related]
27. Uses and production of chiral 3-hydroxy-gamma-butyrolactones and structurally related chemicals.
Lee SH; Park OJ
Appl Microbiol Biotechnol; 2009 Oct; 84(5):817-28. PubMed ID: 19652966
[TBL] [Abstract][Full Text] [Related]
28. Controlling chirality in enzymatic synthesis.
Hodgson J
Biotechnology (N Y); 1992 Oct; 10(10):1093-7. PubMed ID: 1368788
[No Abstract] [Full Text] [Related]
29. New opportunities for biocatalysis: making pharmaceutical processes greener.
Woodley JM
Trends Biotechnol; 2008 Jun; 26(6):321-7. PubMed ID: 18436317
[TBL] [Abstract][Full Text] [Related]
30. Hydroformylation and carbonylation processes: new trends in the synthesis of pharmaceuticals.
Chaudhari RV
Curr Opin Drug Discov Devel; 2008 Nov; 11(6):820-8. PubMed ID: 18946846
[TBL] [Abstract][Full Text] [Related]
31. Integrated operation of continuous chromatography and biotransformations for the generic high yield production of fine chemicals.
Bechtold M; Makart S; Heinemann M; Panke S
J Biotechnol; 2006 Jun; 124(1):146-62. PubMed ID: 16516996
[TBL] [Abstract][Full Text] [Related]
32. Biocatalysts for the pharmaceutical industry created by structure-guided directed evolution of stereoselective enzymes.
Li G; Wang JB; Reetz MT
Bioorg Med Chem; 2018 Apr; 26(7):1241-1251. PubMed ID: 28693917
[TBL] [Abstract][Full Text] [Related]
33. Approaches for multi-gram scale isolation of enantiomers for drug discovery.
Rossi D; Tarantino M; Rossino G; Rui M; Juza M; Collina S
Expert Opin Drug Discov; 2017 Dec; 12(12):1253-1269. PubMed ID: 28971706
[TBL] [Abstract][Full Text] [Related]
34. Stereoselective heterocycle synthesis through oxidative carbon-hydrogen bond activation.
Liu L; Floreancig PE
Curr Opin Drug Discov Devel; 2010; 13(6):733-47. PubMed ID: 21061234
[TBL] [Abstract][Full Text] [Related]
35. Recent Advances in Lipase-Mediated Preparation of Pharmaceuticals and Their Intermediates.
Carvalho AC; Fonseca Tde S; de Mattos MC; de Oliveira Mda C; de Lemos TL; Molinari F; Romano D; Serra I
Int J Mol Sci; 2015 Dec; 16(12):29682-716. PubMed ID: 26690428
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of chiral building blocks for use in drug discovery.
Marino ST; Stachurska-Buczek D; Huggins DA; Krywult BM; Sheehan CS; Nguyen T; Choi N; Parsons JG; Griffiths PG; James IW; Bray AM; White JM; Boyce RS
Molecules; 2004 May; 9(6):405-26. PubMed ID: 18007441
[TBL] [Abstract][Full Text] [Related]
37. Recent trends and novel concepts in cofactor-dependent biotransformations.
Kara S; Schrittwieser JH; Hollmann F; Ansorge-Schumacher MB
Appl Microbiol Biotechnol; 2014 Feb; 98(4):1517-29. PubMed ID: 24362856
[TBL] [Abstract][Full Text] [Related]
38. Biocatalytic synthesis of optically active tertiary alcohols.
Kourist R; Bornscheuer UT
Appl Microbiol Biotechnol; 2011 Aug; 91(3):505-17. PubMed ID: 21691783
[TBL] [Abstract][Full Text] [Related]
39. Asymmetric syntheses and transformations--tools for chirality multiplication in drug synthesis.
Gawroński J
Acta Pol Pharm; 2006; 63(5):333-51. PubMed ID: 17357583
[TBL] [Abstract][Full Text] [Related]
40. A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States.
Miller CP; Ullrich JW
Chirality; 2008 Jun; 20(6):762-70. PubMed ID: 18200591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
